The chemotherapy/radiation balance in advanced Hodgkin's lymphoma: Overweight which side?

被引：8

作者：

Carde, P ^{[1
]}

机构：

[1] Inst Gustave Roussy, Villejuif, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 36期

关键词：

D O I：

10.1200/JCO.2005.04.4644

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9058 / 9062

页数：5

共 42 条

[1] Involved-field radiotherapy for advanced Hodgkin's lymphoma [J].

Aleman, BMP ;

Raemaekers, JMM ;

Tirelli, U ;

Bortolus, R ;

van't Veer, MB ;

Lybeert, MLM ;

Keuning, JJ ;

Carde, P ;

Girinsky, T ;

van der Maazen, RWM ;

Tomsic, R ;

Vovk, M ;

van Hoof, A ;

Demeestere, G ;

Lugtenburg, PJ ;

Thomas, J ;

Schroyens, W ;

De Boeck, K ;

Baars, JW ;

Kluin-Nelemans, JC ;

Carrie, C ;

Aoudjhane, M ;

Bron, D ;

Eghbali, H ;

Smit, WGJM ;

Meerwaldt, JH ;

Hagenbeek, A ;

Pinna, A ;

Henry-Amar, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2396-2406

[2] BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT [J].

BARTLETT, NL ;

ROSENBERG, SA ;

HOPPE, RT ;

HANCOCK, SL ;

HORNING, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1080-1088

[3] ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results [J].

Bonadonna, G ;

Bonfante, V ;

Viviani, S ;

Di Russo, A ;

Villani, F ;

Valagussa, P .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2835-2841

[4] Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease [J].

Brosteanu, O ;

Hasenclever, D ;

Loeffler, M ;

Diehl, V .

ANNALS OF HEMATOLOGY, 2004, 83 (03) :176-182

[5] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].

CANELLOS, GP ;

ANDERSON, JR ;

PROPERT, KJ ;

NISSEN, N ;

COOPER, MR ;

HENDERSON, ES ;

GREEN, MR ;

GOTTLIEB, A ;

PETERSON, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484

[6] Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up [J].

Canellos, GP ;

Gollub, J ;

Neuberg, D ;

Mauch, P ;

Shulman, LN .

ANNALS OF ONCOLOGY, 2003, 14 (02) :268-272

[7]

Carde P, 2000, Hematol J, V1, P282, DOI 10.1038/sj.thj.6200037

[8] Early response to chemotherapy:: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? [J].

Carde, P ;

Koscielny, S ;

Franklin, J ;

Axdorph, U ;

Raemaekers, J ;

Diehl, V ;

Aleman, B ;

Brosteanu, O ;

Hasenclever, D ;

Oberlin, O ;

Bonvin, N ;

Björkholm, M .

ANNALS OF ONCOLOGY, 2002, 13 :86-91

[9]

Carde P, 2004, AM SOC CLIN ONCOL ED, P400

[10]

Carde PP, 2005, J CLIN ONCOL, V23, p563S

← 1 2 3 4 5 →